Stock Taper

PHARMSTANDARD INTERNATIONAL S.A.

Latest 13F filing data - Q3 2018

Holdings

(Top positions)
STOCKTICKERSHARES HELD VALUE
Protagonist Therapeutics, Inc.PTGX750.63K$7.72M